The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1

Ingmar Blümcke(Universitätsklinikum Erlangen), Maria Thom(University College London), Eleonora Aronica(Stichting Epilepsie Instellingen Nederland), Dawna D. Armstrong(Texas Children's Hospital), Harry V. Vinters, André Palmini, Thomas S. Jacques(University College London), G. Avanzini(Fondazione IRCCS Istituto Neurologico Carlo Besta), A. James Barkovich, Giorgio Battaglia(Fondazione IRCCS Istituto Neurologico Carlo Besta), Albert J. Becker(University Hospital Bonn), Carlos Cepeda, Fernando Cendes(Universidade Estadual de Campinas (UNICAMP)), N. Colombo(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Peter B. Crino, J. Helen Cross(Great Ormond Street Hospital), Olivier Delalande(Fondation de Rothschild), François Dubeau(Montreal Neurological Institute and Hospital), John S. Duncan(University College London), Renzo Guerrini(Meyer Children's Hospital), Philippe Kahane(Inserm), Gary W. Mathern, Imad Najm, Çiğdem Özkara(Istanbul University), Charles Raybaud(Hospital for Sick Children), Alfonso Represa(Inserm), Steven N. Roper, Noriko Salamon, Andreas Schulze‐Bonhage(University Medical Center Freiburg), Laura Tassi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Annamaria Vezzani(Mario Negri Institute for Pharmacological Research), Roberto Spreafico(Fondazione IRCCS Istituto Neurologico Carlo Besta)
Epilepsia
November 10, 2010
Cited by 1,735Open Access
Full Text

Abstract

PURPOSE: Focal cortical dysplasias (FCD) are localized regions of malformed cerebral cortex and are very frequently associated with epilepsy in both children and adults. A broad spectrum of histopathology has been included in the diagnosis of FCD. An ILAE task force proposes an international consensus classification system to better characterize specific clinicopathological FCD entities. METHODS: Thirty-two Task Force members have reevaluated available data on electroclinical presentation, imaging, neuropathological examination of surgical specimens as well as postsurgical outcome. KEY FINDINGS: The ILAE Task Force proposes a three-tiered classification system. FCD Type I refers to isolated lesions, which present either as radial (FCD Type Ia) or tangential (FCD Type Ib) dyslamination of the neocortex, microscopically identified in one or multiple lobes. FCD Type II is an isolated lesion characterized by cortical dyslamination and dysmorphic neurons without (Type IIa) or with balloon cells (Type IIb). Hence, the major change since a prior classification represents the introduction of FCD Type III, which occurs in combination with hippocampal sclerosis (FCD Type IIIa), or with epilepsy-associated tumors (FCD Type IIIb). FCD Type IIIc is found adjacent to vascular malformations, whereas FCD Type IIId can be diagnosed in association with epileptogenic lesions acquired in early life (i.e., traumatic injury, ischemic injury or encephalitis). SIGNIFICANCE: This three-tiered classification system will be an important basis to evaluate imaging, electroclinical features, and postsurgical seizure control as well as to explore underlying molecular pathomechanisms in FCD.


Related Papers

No related papers found

Powered by citation graph analysis